These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 455821

  • 1. Uremic middle molecules exist and are biologically active.
    Bergström J, Fürst P, Zimmerman L.
    Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
    [No Abstract] [Full Text] [Related]

  • 2. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J.
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [Abstract] [Full Text] [Related]

  • 3. Middle molecules in uraemia.
    Fürst P, Asaba M, Gordon A, Zimmerman L, Bergström J.
    Proc Eur Dial Transplant Assoc; 1975 May; 11():417-26. PubMed ID: 1105558
    [No Abstract] [Full Text] [Related]

  • 4. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H, Bergström J, Fürst P, Johnson C, Yahiel V.
    Artif Organs; 1981 May; 4 Suppl():137-42. PubMed ID: 7295080
    [Abstract] [Full Text] [Related]

  • 5. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K, Kidawa Z, Walasek L, Lutz W.
    Pol Tyg Lek; 1978 Feb 13; 33(7):257-9. PubMed ID: 758030
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum middle molecules in uremia.
    Buzio C, Manari A, Calderini C, Montagna G, Migone L.
    Artif Organs; 1981 Feb 13; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract] [Full Text] [Related]

  • 8. ["The middle molecules" are uremic toxins (author's transl)].
    Hanicki Z, Cichocki T.
    Przegl Lek; 1978 Feb 13; 35(2):301-5. PubMed ID: 652997
    [No Abstract] [Full Text] [Related]

  • 9. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation].
    Buzio C, Dall'Aglio PP, Delmonte G, Montagna G, Migone L.
    Minerva Nefrol; 1979 Feb 13; 26(1):45-8. PubMed ID: 471320
    [No Abstract] [Full Text] [Related]

  • 10. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS, Levitskiĭ ER, Poddubnaia LP, Gabriélian NI.
    Anesteziol Reanimatol; 1987 Feb 13; (2):37-42. PubMed ID: 3300433
    [No Abstract] [Full Text] [Related]

  • 11. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
    Gordon A, Berström J, Fürst P, Zimmerman L.
    Kidney Int Suppl; 1975 Jan 13; (2):45-51. PubMed ID: 1057692
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Determination of middle molecules in uremic patients.
    Wu ZG, Cai ZH, Lu ZN, Liao LT, Zhu SQ.
    Chin Med J (Engl); 1985 Feb 13; 98(2):115-20. PubMed ID: 3922688
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A, Myśliwiec M, Soszka J.
    Pol Tyg Lek; 1985 Feb 13; 45(40-41):810-3. PubMed ID: 2096374
    [Abstract] [Full Text] [Related]

  • 16. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P, Zimmerman L, Bergström J.
    Clin Nephrol; 1976 Apr 13; 3(2):178-88. PubMed ID: 1277595
    [Abstract] [Full Text] [Related]

  • 17. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W.
    Pol Tyg Lek; 1976 Jul 05; 31(27):1173-6. PubMed ID: 951302
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G, Albano V, Tancredi M, Daniele M, Pignatelli F.
    Biomater Artif Cells Artif Organs; 1987 Jul 05; 15(1):175-81. PubMed ID: 3449135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.